A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

NCT06594393 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidermolysis Bullosa (EB)
Dystrophic Epidermolysis Bullosa
Junctional Epidermolysis Bullosa

Interventions

DRUG: TCP-25 gel
DRUG: Vehicle (placebo)

Sponsor

Xinnate AB